Every possible advantage

At Paragonix, our mission is to create a new standard for organ transport that improves patient outcomes worldwide. We strive to protect the ultimate donation with the dignity and safety it deserves in order to give patients every possible advantage.

This award winning, first-of-its-kind device provides a sterile, temperature and pressure controlled environment for hearts traveling between operating rooms. The product is designed to be easy-to-use in stressful, fast-paced environments where there is no room for mistakes.

In 2020, the Paragonix SherpaPak CTS became the cited technology to prevent freezing in the Consensus Statement from ISHLT on donor heart and lung procurement.

 The SherpaPak CTS device is also the only commercially-available FDA-cleared and CE-marked medical device for heart transportation.


GUARDIAN is the global utilization and registry database for improved heart preservation. The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor hearts that were preserved and transported using the Paragonix SherpaPak™ Cardiac Transport System.

Thank you.

To the healthcare workers, scientists, and researchers around the world fighting COVID-19: Thank you for all that you are doing to put patients first.

Below is a link for cardiac transplant professionals to an up to date collection of resources on cardiac transplantation in the COVID-19 environment.

Request more information